Skip to content
March 29, 2024

Equity.Guru

Investment information for the new generation

Search

Autism Spectrum Disorder

Nova Mentis Life Science (NOVA.C) announced it has filed for orphan drug designation with the European Medicines Agency (EMA) for its propriety psilocybin drug to help treat patients with fragile…
When you write about the psychedelics industry, most of the people you speak with are corporate executives and most of what you read comes from PR personnel, so speaking…
Nova Mentis Life Science (NOVA.C) announced early indications of a rescue effect through psilocybin use on anxiety-like behaviours related to autism spectrum disorder (ASD).   The research involved studying…